![]() |
市場調査レポート
商品コード
1439650
美容インプラント - 世界市場の考察、競合情勢、市場予測(2030年)Aesthetic Implants - Market Insights, Competitive Landscape, and Market Forecast - 2030 |
||||||
カスタマイズ可能
適宜更新あり
|
美容インプラント - 世界市場の考察、競合情勢、市場予測(2030年) |
出版日: 2024年02月01日
発行: DelveInsight
ページ情報: 英文 150 Pages
納期: 2~10営業日
|
世界の美容インプラントの市場規模は、2024年~2030年の予測期間にCAGRで7.82%の成長が見込まれます。市場は、乳がんの有病率の増加、美容手術や再建整形手術の増加、美容インプラントに関連する製品の発売の増加、魅力的な身体の外見へのニーズの増加などのさまざまな要因によってプラス成長を示しています。したがって、市場は2024年~2030年の予測期間に大幅なCAGRで成長すると推定されます。
美容インプラントの市場力学
美容インプラント市場の主な促進要因の1つは、世界中での乳がんの有病率の増加です。例えば、世界保健機関(WHO)が2023年に発表したデータによると、2020年に世界中で230万人の女性が乳がんと診断されました。同じ資料と統計によれば、全世界で、過去5年間に780万人の女性が乳がんと診断されています。したがって、世界中での乳がんの有病率の増加に伴い、乳房インプラントのニーズも急増する可能性があり、予測期間(2024年~2030年)に美容インプラント市場全体を牽引します。
さらに、美容インプラント市場のもう1つの主な成長要因が、美容手術や再建手術の増加です。例えば、2020年のPlastic Surgery Statistics Reportによると、アメリカでは1,560万件の美容整形手術のうち、230万件が美容外科手術であったのに対し、1,320万件が低侵襲手術でした。上記の資料によると、2020年の再建手術は680万件(2019年比3%増)でした。さらに、上記の資料によれば、2020年の豊胸手術は19万3,073件で、シリコンインプラントが全体の84%を占め、生理食塩水インプラントは16%でした。したがって、美容手術や再建手術の増加は、美容インプラントの需要を増加させ、それによって美容インプラント市場全体の成長を促進します。
したがって、2024年~2030年の予測期間に、上記の要因が総体的に美容インプラント市場を牽引します。
しかし、美容インプラントに関連する感染症や美容インプラントの高いコストが、世界の美容インプラント市場の成長を妨げる可能性があります。
COVID-19パンデミックは、入院が制限されただけでなく、COVID-19に罹患した患者に比べて選択的手術が優先されなかったことから、美容インプラント市場に悪影響を与えました。ロックダウン規制、スタッフの不足、マスクやPPEキットの不足は、手術を求める患者の入院に大きな影響を与えました。しかし、大衆のワクチン接種、ロックダウン規制の緩和、選択的手術の再開、マスク、PPEキット、スタッフの利用可能性、これらすべての対策が軌道に乗ったことで、美容インプラント市場は再び勢いを取り戻し、2024年~2030年の予測期間にさらなる成長が見込まれています。
北米が美容インプラント市場全体を独占すると予測されます。
すべての地域の中で、北米が2023年に世界の美容インプラント市場を独占し、2024年~2030年の予測期間も同様である見込みです。乳がんの有病率の増加や美容インプラント関連の製品の発売の増加などの要因が、北米市場における美容インプラントの需要を増加させると予測されています。
American Cancer Societyが2023年に発表した最新のデータによると、米国では2022年末までに45歳以下の女性の8人に1人が浸潤性乳がんに罹患し、浸潤性乳がんの3人に2人が55歳以上の女性と診断されています。したがって、乳がんの有病率の増加に伴い、乳房インプラントのニーズも急増する可能性があり、予測期間(2024年~2030年)に美容インプラント市場全体を牽引する可能性があります。
さらに、美容インプラントに関連する製品の発売の増加といったその他の要因も、同地域の美容インプラント市場全体を牽引する可能性があります。例えば、2022年2月、世界最大の美容医療専業企業であるMerz Aestheticsは米国で、21歳以上の成人における中等度から重度の顎ラインの輪郭の喪失を改善するための軟組織増強に向けた深部注入(皮下と/または骨膜上)に使用する、Radiesse®(+)Lidocaine注入型インプラントの商業的発売を発表しました。
したがって、前述の要因の相互作用が、美容インプラント市場において北米地域の成長に有利な環境をもたらす可能性があります。
当レポートでは、世界の美容インプラント市場について調査分析し、市場規模と予測、促進要因と課題、企業と製品のプロファイルなどを提供しています。
Aesthetic Implants Market By Product Type (Breast Implants, Body Contouring Implants, Custom-Made Implants, Nasal Implants, Dental Implants, And Others), By Gender (Male And Female), By End-User (Hospitals, Cosmetology Clinics, And Ambulatory Surgical Centers), and by geography is expected to grow at a steady CAGR forecast till 2030 owing to increasing prevalence of breast cancer and increase in number of cosmetic & reconstructive plastic surgeries
The global aesthetic implants market is estimated to grow at a CAGR of 7.82% during the forecast period from 2024 to 2030. The aesthetic implants market is witnessing positive growth owing to various factors such as the increasing prevalence of breast cancer, increase in the number of cosmetic & reconstructive surgeries, rise in the product launches related to aesthetic implants, and increasing need for attractive physical appearance. Therefore, the market for aesthetic implants is estimated to grow at a significant CAGR during the forecast period from 2024 to 2030.
Aesthetic Implants Market Dynamics:
One of the main drivers of the aesthetic implant market is the increasing prevalence of breast cancer globally. For instance, as per the World Health Organization (WHO) published data in the year 2023, in 2020, 2.3 million women were diagnosed with breast cancer throughout the world. According to the same source and statistics, across the world, 7.8 million women would have been diagnosed with breast cancer in the previous five years. Therefore, with the increasing global prevalence of breast cancer, the need for breast implants could also surge, driving the overall aesthetic implants market forward over the forecast period (2024-2030).
Moreover, another key factor that is responsible for the growth of the aesthetic implants market is the increase in the number of cosmetic & reconstructive surgeries. For instance, as per the plastic surgery statistics report in the year 2020, in America, out of 15.6 million cosmetic procedures, 2.3 million were cosmetic surgical procedures whereas 13.2 million procedures were minimally-invasive. According to the source mentioned above, in 2020, reconstructive procedures were 6.8 Million (a 3% increase from 2019). Additionally, as per the above-referenced source, in 2020, there were 193,073 breast augmentations, silicone implants accounting for 84% of all procedures, and saline implants accounting for 16%. Thus, an increase in the number of cosmetic & reconstructive surgeries will increase the demand for aesthetic implants, thereby propelling the growth of aesthetic implants' overall market.
Therefore, the factors stated above collectively will drive the aesthetic implants market during the forecast period from 2024-2030.
However, infections associated with the aesthetic implants and the high cost of aesthetic implants can hamper the global aesthetic implant market growth
The Coronavirus pandemic (COVID-19) has negatively impacted the market for aesthetic implants as hospital admissions were limited, as well as elective surgeries were not a priority in comparison to the patients suffering from COVID. Lockdown restrictions, lack of staff, and shortage of masks and PPE kits made a huge impact on patient admissions in hospitals for surgeries. However, with masses being vaccinated, lockdown restriction relaxation, resumption of elective surgeries, and availability of masks, PPE kits, and staff, with all these measures back on track the aesthetic implants market has picked momentum again and is expected to further grow during the forecast period from 2024-2030.
Aesthetic Implants Market Segment Analysis:
Aesthetic Implants Market by Product Type (Breast Implant, Body Contouring Implants, Custom-Made Implants, Nasal Implants, Dental Implants, and Others), Gender (Male and Female), End-User (Hospitals, Cosmetology Clinics, and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)
In by product type segment of the dental implants market, is expected to share a significant revenue share in the year 2023. Benefits associated with dental implants are, as they are used to prevent bone loss, they act like natural teeth, the implants last a lifetime, they can be required to keep adjacent teeth stable, improve the appearance, oral health, self-esteem as well as speech, they are durable, help to get free from gum disease, help to prevent facial sagging & premature aging. Thus, these benefits associated with dental implants can increase the demand for aesthetic implants, which could drive the aesthetic implants' overall market growth.
However, various technologically advanced aesthetic implants receive approvals, this can also be expected to drive the overall market growth for aesthetic implants. For instance, in June 2022, Biotech Dental SAS, a designer and manufacturer of medical devices and digital solutions for dental surgeons, orthodontists, and dental prosthesis laboratories, received United States (US) Food and Drug Administration (FDA) approval for Kontact Dental Implant System, the implant system is designed to support single-unit, multiple-unit, or overdenture dental restorations in partly or completely edentulous patients.
Moreover, due to the interplay of all the factors mentioned above, this can result in the rising demand for aesthetic implants, which in turn would provide a conducive growth environment for the overall aesthetic implants market during the forecast period from 2024-2030.
North America is expected to dominate the overall Aesthetic Implants Market:
Among all the regions, North America is expected to dominate the global aesthetic implants market in the year 2023 and is expected to do the same during the forecast period from 2024-2030. Factors such as the increasing prevalence of breast cancer and the rise in product launches related to aesthetic implants are expected to increase the demand of aesthetic implants in the North America market.
According to the latest data published by the American Cancer Society in the year 2023, in the United States, one out of every eight women under the age of 45 will acquire invasive breast cancer by the end of the year 2022, and two out of every three invasive breast cancers will be diagnosed in women 55 and older. Thus, with the increasing prevalence of breast cancer, the need for breast implants could also surge, this can drive the overall aesthetic implants market forward over the forecast period (2024-2030).
Furthermore, another factor such as the rise in the product launches related to aesthetic implants could drive the aesthetic implant's overall market in the region. For instance, in February 2022, Merz Aesthetics, the world's largest dedicated medical aesthetics company, announced the commercial launch of Radiesse® (+) Lidocaine injectable implant, for deep injection (subdermal and/or supraperiosteal) in the United States for soft tissue augmentation to improve moderate to a severe loss of jawline contour in adults over the age of 21.
Therefore, the interplay of the aforementioned factors would provide a conducive growth environment for the North American region in the aesthetic implants market.
Aesthetic Implants Market Key Players:
Some of the key market players operating in the aesthetic implants market include POLYTECH Health & Aesthetics GmbH, Sientra, Inc, Surgiform Innovative Surgical Products, GC Aesthetics, Dentsply Sirona, Institut Straumann AG, AVINENT, AbbVie, Establishment Labs S.A., Mentor (Johnson & Johnson Medical Ltd), 3M, Zimmer Biomet, Alpha Aesthetics, Symatese, Integra LifeSciences, Sebbin, IDEAL IMPLANT INCORPORATED, Lattice Medical, CEREPLAS, Guangzhou Wanhe Plastic Material Co Ltd, and among others.
Recent Developmental Activities in the Aesthetic Implants:
In May 2022, GC Aesthetics®, Inc. (GCA), a privately-held medical technology company providing healthcare aesthetic solutions, announced the launch of an Innovative Nipple Areola Complex (NAC) Reconstruction Implant: FixNip(TM) NRI
In May 2022, GC Aesthetics, Inc., a privately-held medical technology company providing aesthetic solutions for global healthcare markets, announced the launch of its next generation of breast implants, PERLE(TM). It's a cutting-edge series of smooth breast implants with a proprietary surface technology (BioQ(TM)), GCA's industry-leading gel technology (EmunomicTM Breast Tissue Dynamic Gel), and an upgraded version of GCA's long-term great safety record
In November 2019, BellaSeno, a German additive manufacturing start-up & Evonik, a chemical company, BellaSeno, and Evonik have formed a long-term partnership to develop a new breast implant technology based on Evonik's RESOMER bioresorbable polymer. RESOMER will be used in BellaSeno's 3D-printed senella breast scaffold. The product is designed to be used after reconstruction, augmentation, or revision surgery. It is resorbed by the body and gradually replaced by natural breast tissue
Key Takeaways from the Aesthetic Implants Market Report Study:
Target Audience who can be benefited from this Aesthetic Implants Market Report Study:
Frequently Asked Questions for Aesthetic Implants:
Aesthetic implant placement is driven by both a restorative and biological philosophy. The implant is positioned to meet the contour requirements for a good repair and should be positioned biologically to allow for the preservation of both hard and soft tissue architecture.
The global aesthetic implants market is estimated to grow at a CAGR of 7.82% during the forecast period from 2024 to 2030.
The Aesthetic implants market is witnessing positive market growth owing to the factors such as the increasing prevalence of breast cancer, increase in the number of cosmetic & reconstructive surgeries, rise in the product launches related to aesthetic implants, and increasing need for attractive physical appearance
Some of the key market players operating in the Aesthetic implants market include POLYTECH Health & Aesthetics GmbH, Sientra, Inc, Surgiform Innovative Surgical Products, GC Aesthetics, Dentsply Sirona, Institut Straumann AG, AVINENT, AbbVie, Establishment Labs S.A., Mentor (Johnson & Johnson Medical Ltd), 3M, Zimmer Biomet, Alpha Aesthetics, Symatese, Integra LifeSciences, Sebbin, IDEAL IMPLANT INCORPORATED, Lattice Medical, CEREPLAS, Guangzhou Wanhe Plastic Material Co Ltd, and among others.
North America is expected to dominate the global aesthetic implants market. Factors contributing to the growth are the increasing prevalence of breast cancer and the rise in product launches related to aesthetic implants, which are contributing to the growth of the aesthetic implants market in the North America region.